An AllTrials project

NCT02603809: A reported trial by Idorsia Pharmaceuticals Ltd.

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT02603809
Title A Multi-center, Double-blind, Double-dummy, Randomized, Placebo- and Active-reference, Parallel Group, Phase 2, Dose-finding Study With ACT-132577 in Subjects With Essential Hypertension (Grade 1 and 2).
Results Status Reported
ACT or pACT? This is what FDAAA officially calls a "probable Applicable Clinical Trial"
Start date Dec. 14, 2015
Completion date Feb. 28, 2017
Required reporting date Feb. 28, 2020, midnight
Actual reporting date Feb. 27, 2020
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None